ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells

Properties of cancer stem cells involved in drug resistance and relapse have significant effects on clinical outcome. Although tyrosine kinase inhibitors (TKIs) have dramatically improved survival of patients with chronic myeloid leukemia (CML), TKIs have not fully cured CML due to TKI-resistant CML...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Reports
Autors principals: Miyauchi, Masashi, Koya, Junji, Arai, Shunya, Yamazaki, Sho, Honda, Akira, Kataoka, Keisuke, Yoshimi, Akihide, Taoka, Kazuki, Kumano, Keiki, Kurokawa, Mineo
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5919294/
https://ncbi.nlm.nih.gov/pubmed/29429960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stemcr.2018.01.015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars